Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'factor IX' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 1347 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Chang, TJ; Mohamed, S; Hambleton, J
      Hemophilic arthropathy: Considerations in management

      JOURNAL OF THE AMERICAN PODIATRIC MEDICAL ASSOCIATION
    2. Zinn, AR; Ross, JL
      Molecular analysis of genes on Xp controlling turner syndrome and premature ovarian failure (POF)

      SEMINARS IN REPRODUCTIVE MEDICINE
    3. Favre, D; Provost, N; Blouin, V; Blacho, G; Cherel, Y; Salvetti, A; Moullier, P
      Immediate and long-term safety of recombinant adeno-associated virus injection into the nonhuman primate muscle

      MOLECULAR THERAPY
    4. Arruda, VR; Fields, PA; Milner, R; Wainwright, L; De Miguel, MP; Donovan, PJ; Herzog, RW; Nichols, TC; Biegel, JA; Razavi, M; Dake, M; Huff, D; Flake, AW; Couto, L; Kay, MA; High, KA
      Lack of germline transmission of vector sequences following systemic administration of recombinant AAV-2 vector in males

      MOLECULAR THERAPY
    5. Park, F; Kay, MA
      Modified HIV-1 based lentiviral vectors have an effect on viral transduction efficiency and gene expression in vitro and in vivo

      MOLECULAR THERAPY
    6. Nicklin, SA; Buening, H; Dishart, KL; de Alwis, M; Girod, A; Hacker, U; Thrasher, AJ; Ali, RR; Hallek, M; Baker, AH
      Efficient and selective AAV2-mediated gene transfer directed to human vascular endothelial cells

      MOLECULAR THERAPY
    7. Herzog, RW; Mount, JD; Arruda, VR; High, KA; Lothrop, CD
      Muscle-directed gene transfer and transient immune suppression result in sustained partial correction of canine hemophilia B caused by a null mutation

      MOLECULAR THERAPY
    8. Fields, PA; Arruda, VR; Armstrong, E; Chu, K; Mingozzi, F; Hagstrom, JN; Herzog, RW; High, KA
      Risk and prevention of anti-factor IX formation in AAV-mediated gene transfer in the context of a large deletion of F9

      MOLECULAR THERAPY
    9. Chao, HJ; Monahan, PE; Liu, YB; Samulski, RJ; Walsh, CE
      Sustained and complete phenotype correction of hemophilia B mice followingintramuscular injection of AAV1 serotype vectors

      MOLECULAR THERAPY
    10. Miao, CH; Thompson, AR; Loeb, K; Ye, X
      Long-term and therapeutic-level hepatic gene expression of human factor IXafter naked plasmid transfer in vivo

      MOLECULAR THERAPY
    11. Sung, RS; Qin, LH; Bromberg, JS
      TNF alpha and IFN gamma induced by innate anti-adenoviral immune responsesinhibit adenovirus-mediated transgene expression

      MOLECULAR THERAPY
    12. Zhang, XW; Li, CY
      Generation of recombinant adeno-associated virus vectors by a complete adenovirus-mediated approach

      MOLECULAR THERAPY
    13. Fewell, JG; MacLaughlin, F; Mehta, V; Gondo, M; Nicol, F; Wilson, E; Smith, LC
      Gene therapy for the treatment of hemophilia B using PINC-formulated plasmid delivered to muscle with electroporation

      MOLECULAR THERAPY
    14. Lipshutz, GS; Gruber, CA; Cao, YA; Hardy, J; Contag, CH; Gaensler, KML
      In utero delivery of adeno-associated viral vectors: Intraperitoneal gene transfer produces long-term expression

      MOLECULAR THERAPY
    15. Chen, ZY; Yant, SR; He, CY; Meuse, L; Shen, S; Kay, MA
      Linear DNAs concatemerize in vivo and result in sustained transgene expression in mouse liver

      MOLECULAR THERAPY
    16. Tao, NJ; Gao, GP; Parr, M; Johnston, J; Baradet, T; Wilson, JM; Barsoum, J; Fawell, SE
      Sequestration of adenoviral vector by Kupffer cells leads to a nonlinear dose response of transduction in liver

      MOLECULAR THERAPY
    17. Wolfe, D; Goins, WF; Kaplan, TJ; Capuano, SV; Fradette, J; Murphey-Corb, M; Robbins, PD; Cohen, JB; Glorioso, JC
      Herpesvirus-mediated systemic delivery of nerve growth factor

      MOLECULAR THERAPY
    18. Lai, LW; Lien, YHH
      Therapeutic application of chimeric RNA/DNA oligonucleotide based gene therapy

      EXPERT OPINION ON BIOLOGICAL THERAPY
    19. Husi, H; Walkinshaw, MD
      Purification of factor X by hydrophobic interaction chromatography

      JOURNAL OF CHROMATOGRAPHY B
    20. Ghivizzani, SC; Oligino, TJ; Glorioso, JC; Robbins, PD; Evans, CH
      Direct gene delivery strategies for the treatment of rheumatoid arthritis

      DRUG DISCOVERY TODAY
    21. Liras, A
      Gene therapy for haemophilia: the end of a 'royal pathology' in the third millennium?

      HAEMOPHILIA
    22. Rizza, CR; Hill, FGH; Spooner, RJD; Giangrande, PLF
      Treatment of haemophilia in the United Kingdom 1981-1996

      HAEMOPHILIA
    23. Berntorp, E; Petrini, P; Dockter, G; Tengborn, L; Wendisch, I; Eberl, W; Aumann, V; Frade, G; Seliger, I; Engl, W; Ehrlich, H
      An approach to study the viral safety of plasma-derived products in previously treated, non-infected patients

      HAEMOPHILIA
    24. Josic, D; Kannicht, C; Loster, K; Pock, K; Iberer, G; Buchacher, A
      Vitronectin in clotting factor IX concentrates

      HAEMOPHILIA
    25. Faradji, A; Bonnomet, F; Lecocq, J; Grunebaum, L; Desprez, D; Kern, O; Barbier, L; Sibilia, J
      Knee joint arthroplasty in a patient with haemophilia A and high inhibitortitre using recombinant factor VIIa (NovoSeven((R))): a new case report and review of the literature

      HAEMOPHILIA
    26. Bjorkman, S; Shapiro, AD; Berntorp, E
      Pharmacokinetics of recombinant factor IX in relation to age of the patient: implications for dosing in prophylaxis

      HAEMOPHILIA
    27. Chowdary, P; Dasani, H; Jones, JAH; Loran, CM; Eldridge, A; Hughes, S; Collins, PW
      Recombinant factor IX (BeneFix (R)) by adjusted continuous infusion: a study of stability, sterility and clinical experience

      HAEMOPHILIA
    28. Haya, S; Lopez, MF; Aznar, JA; Batlle, J
      Immune tolerance treatment in haemophilia patients with inhibitors: the Spanish Registry

      HAEMOPHILIA
    29. Hortelano, G; Wang, L; Xu, N; Ofosu, FA
      Sustained and therapeutic delivery of factor IX in nude haemophilia B miceby encapsulated C2C12 myoblasts: concurrent tumourigenesis

      HAEMOPHILIA
    30. Miller, R
      The responsibility of separating truth from myth to patient and family

      HAEMOPHILIA
    31. Hoots, WK
      The future of plasma-derived clotting factor concentrates

      HAEMOPHILIA
    32. High, KA
      Gene therapy: a 2001 perspective

      HAEMOPHILIA
    33. Turgeman, G; Pittman, DD; Muller, R; Kurkalli, BG; Zhou, SH; Pelled, G; Peyser, A; Zilberman, Y; Moutsatsos, IK; Gazit, D
      Engineered human mesenchymal stem cells: a novel platform for skeletal cell mediated gene therapy

      JOURNAL OF GENE MEDICINE
    34. Sarukhan, A; Soudais, C; Danos, O; Jooss, K
      F;actors influencing cross-presentation of non-self antigens expressed from recombinant adeno-associated virus vectors

      JOURNAL OF GENE MEDICINE
    35. Herweijer, H; Zhang, GF; Subbotin, VM; Budker, V; Williams, P; Wolff, JA
      Time course of gene expression after plasmid DNA gene transfer to the liver

      JOURNAL OF GENE MEDICINE
    36. Chuah, MKL; Collen, D; VandenDriessche, T
      Gene therapy for hemophilia

      JOURNAL OF GENE MEDICINE
    37. Chan, JCY
      Gene targeting in hemostasis. Factor VII

      FRONTIERS IN BIOSCIENCE
    38. Gailani, D
      Gene targeting in hemostasis. Factor XI

      FRONTIERS IN BIOSCIENCE
    39. Tolo, H; Kauppinen, HL; Alm, G; Perers, A; Lindeberg, E; Wahlstedt-Froberg, V; Parkkinen, J
      Development of a highly purified multicomponent leukocyte IFN-alpha product

      JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    40. Santhouse, A
      Accuracy about coagulation products

      AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    41. Poon, MC
      Use of recombinant factor VIIa in hereditary bleeding disorders

      CURRENT OPINION IN HEMATOLOGY
    42. Li, XM; Scaringe, WA; Hill, KA; Roberts, S; Mengos, A; Careri, D; Pinto, MT; Kasper, CK; Sommer, SS
      Frequency of recent retrotransposition events in the human factor IX gene

      HUMAN MUTATION
    43. von Bonsdorff, L; Tolo, H; Lindeberg, L; Nyman, T; Harju, A; Parkkinen, J
      Development of a pharmaceutical apotransferrin product for iron binding therapy

      BIOLOGICALS
    44. Xin, KQ; Urabe, M; Yang, J; Nomiyama, K; Mizukami, H; Hamajima, K; Nomiyama, H; Saito, T; Imai, M; Monahan, J; Okuda, K; Ozawa, K; Okuda, K
      A novel recombinant adeno-associated virus vaccine induces a long-term humoral immune response to human immunodeficiency virus

      HUMAN GENE THERAPY
    45. Donahue, RE; Dunbar, CE
      Update on the use of nonhuman primate models for preclinical testing of gene therapy approaches targeting hematopoietic cells

      HUMAN GENE THERAPY
    46. Xu, LF; Daly, T; Gao, CH; Flotte, TR; Song, SH; Byrne, BJ; Sands, MS; Ponder, KP
      CMV-beta-actin promoter directs higher expression from an adeno-associatedviral vector in the liver than the cytomegalovirus or elongation factor 1 alpha promoter and results in therapeutic levels of human factor X in mice

      HUMAN GENE THERAPY
    47. Tietge, UJF; Sun, GS; Czarnecki, S; Yu, QC; Lohse, P; Du, H; Grabowski, GA; Glick, JM; Rader, DJ
      Phenotypic correction of lipid storage and growth arrest in Wolman diseasefibroblasts by gene transfer of lysosomal acid lipase

      HUMAN GENE THERAPY
    48. Bartholomew, A; Patil, S; Mackay, A; Nelson, M; Buyaner, D; Hardy, W; Mosca, J; Sturgeon, C; Siatskas, M; Mahmud, N; Ferrer, K; Deans, R; Moseley, A; Hoffman, R; Devine, SM
      Baboon mesenchymal stem cells can be genetically modified to secrete humanerythropoietin in vivo

      HUMAN GENE THERAPY
    49. Yang, XQ; Wang, F; Wang, Y; Lu, DR; Qiu, XF; Xue, JL
      Constitutive expression of human coagulating factor IX in HeLa cells by homologous recombination of the promoter

      SCIENCE IN CHINA SERIES C-LIFE SCIENCES
    50. Lu, HH; Chen, L; Wang, XF; Lu, D; Qiu, XF; Xue, JL
      Preparation of a recombinant adeno-associated viral vector with a mutationof human factor IX in large scale and its expression in vitro and in vivo

      CHINESE SCIENCE BULLETIN
    51. Fields, PA; Armstrong, E; Hagstrom, JN; Arruda, VR; Murphy, ML; Farrell, JP; High, KA; Herzog, RW
      Intravenous administration of an E1/E3-deleted adenoviral vector induces tolerance to factor IX in C57BL/6 mice

      GENE THERAPY
    52. Song, S; Embury, J; Laipis, PJ; Berns, KI; Crawford, JM; Flotte, TR
      Stable therapeutic serum levels of human alpha-1 antitrypsin (AAT) after portal vein injection of recombinant adeno-associated virus (rAAV) vectors

      GENE THERAPY
    53. Eldadah, ZA; Hamosh, A; Biery, NJ; Montgomery, RA; Duke, M; Elkins, R; Dietz, HC
      Familial Tetralogy of Fallot caused by mutation in the jagged1 gene

      HUMAN MOLECULAR GENETICS
    54. McKenzie, AW; Georgiou, HM; Zhan, YF; Brady, JL; Lew, AM
      Protection of xenografts by a combination of immunoisolation and a single dose of anti-CD4 antibody

      CELL TRANSPLANTATION
    55. Espinos, E; Liu, JH; Bader, CR; Bernheim, L
      Efficient non-viral DNA-mediated gene transfer to human primary myoblasts using electroporation

      NEUROMUSCULAR DISORDERS
    56. Ravn, HB; Lassen, JF; Bergenhem, N; Kristensen, AT
      Intravenous magnesium does not influence the activity of the coagulation cascade

      BLOOD COAGULATION & FIBRINOLYSIS
    57. Melton, LG; Li, T; Stafford, DW; Gabriel, DA
      Location of the platelet binding site in zymogen coagulation factor IX

      BLOOD COAGULATION & FIBRINOLYSIS
    58. Macek, B; Hofsteenge, J; Peter-Katalinic, J
      Direct determination of glycosylation sites in O-fucosylated glycopeptidesusing nano-electrospray quadrupole time-of-flight mass spectrometry

      RAPID COMMUNICATIONS IN MASS SPECTROMETRY
    59. Silveira, A
      Postprandial triglycerides and blood coagulation

      EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    60. Weitz, JI
      New anticoagulant drugs

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    61. Shirahata, A; Kamiya, T; Takamatsu, J; Kojima, T; Fukutake, K; Arai, M; Hanabusa, H; Tagami, H; Yoshioka, A; Shima, M; Naka, H; Fujita, S; Minamoto, Y; Kamizono, J; Saito, H
      Clinical trial to investigate the pharmacokinetics, pharmacodynamics, safety, and efficacy of recombinant factor VIIa in Japanese patients with hemophilia with inhibitors

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    62. Morishita, E; Yamaguchi, K; Asakura, H; Saito, M; Yamazaki, M; Ontachi, Y; Mizutani, T; Kato, M; Nakao, S
      One missense mutation in the factor X gene causing factor X deficiency - Factor X Kanazawa

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    63. Sommer, SS; Scaringe, WA; Hill, KA
      Human germline mutation in the factor IX gene

      MUTATION RESEARCH-DNA REPAIR
    64. Tobias, CA; Dhoot, NO; Wheatley, MA; Tessler, A; Murray, M; Fischer, I
      Grafting of encapsulated BDNF-producing fibroblasts into the injured spinal cord without immune suppression in adult rats

      JOURNAL OF NEUROTRAUMA
    65. Kling, J
      Hot papers - Hemophilia: Finding the right path - Comment

      SCIENTIST
    66. Berrettini, M; Mariani, G; Schiavoni, M; Rocino, A; Di Paolantonio, T; Longo, G; Morfini, M
      Pharmacokinetic evaluation of recombinant, activated factor VII in patients with inherited factor VII deficiency

      HAEMATOLOGICA
    67. Mariani, G; Kroner, B
      Immune tolerance in hemophilia with factor VIII inhibitors: predictors of success

      HAEMATOLOGICA
    68. Chowdhury, MR; Kabra, M; Menon, PSN
      Factor IX gene polymorphisms in Indian population

      AMERICAN JOURNAL OF HEMATOLOGY
    69. Nuss, R; Soucie, JM; Evatt, B
      Changes in the occurrence of and risk factors for hemophilia-associated intracranial hemorrhage

      AMERICAN JOURNAL OF HEMATOLOGY
    70. Kulkarni, R; Aledort, LM; Berntorp, E; Brackman, HH; Brown, D; Cohen, AR; Ewing, NP; Gringeri, A; Gruppo, R; Hoots, K; Leissenger, C; Peerlinck, K; Poon, MC; Wong, WY
      Therapeutic choices for patients with hemophilia and high-titer inhibitors

      AMERICAN JOURNAL OF HEMATOLOGY
    71. Ewenstein, BM
      Continuous infusion of recombinant factor VIIa: Continue or not?

      THROMBOSIS AND HAEMOSTASIS
    72. Lefkowitz, JB; Nuss, R; Haver, T; Jacobson, L; Thompson, AR; Manco-Johnson, M
      Factor IX Denver, ASN 346 -> ASP mutation resulting in a dysfunctional protein with defective factor VIIIa interaction

      THROMBOSIS AND HAEMOSTASIS
    73. Walsh, PN
      Roles of platelets and factor XI in the initiation of blood coagulation bythrombin

      THROMBOSIS AND HAEMOSTASIS
    74. White, GC
      Gene therapy in hemophilia: Clinical trials update

      THROMBOSIS AND HAEMOSTASIS
    75. de Visser, MCH; Poort, SR; Vos, HL; Rosendaal, FR; Bertina, RM
      Factor X levels, polymorphisms in the promoter region of factor X, and therisk of venous thrombosis

      THROMBOSIS AND HAEMOSTASIS
    76. He, R; Xiong, SL; He, XF; Liu, FY; Han, JZ; Li, JC; He, SL
      The role of factor XI in a dilute thromboplastin assay of extrinsic coagulation pathway

      THROMBOSIS AND HAEMOSTASIS
    77. Keularts, IMLW; Zivelin, A; Seligsohn, U; Hemker, HC; Beguin, S
      The role of factor XI in thrombin generation induced by low concentrationsof tissue factor

      THROMBOSIS AND HAEMOSTASIS
    78. Perera, L; Darden, TA; Pedersen, LG
      Modeling human zymogen factor IX

      THROMBOSIS AND HAEMOSTASIS
    79. Russell, KE; Read, MS; Bellinger, DA; Leitermann, K; Rup, BJ; McCarthy, KP; Keith, JC; Khor, SP; Schaub, RG; Nichols, TC
      Intratracheal administration of recombinant human factor IX (BeneFix (TM))achieves therapeutic levels in hemophilia B dogs

      THROMBOSIS AND HAEMOSTASIS
    80. Oldenburg, J; Kriz, K; Wuillemin, WA; Maly, FE; von Felten, A; Siegemund, A; Keeling, DM; Baker, P; Chu, K; Konkle, BA; Lammle, B; Albert, T
      Genetic predisposition to bleeding during oral anticoagulant therapy: Evidence for common founder mutations (FIXVal-10 and FIXThr-10) and an independent CpG hotspot mutation (FIXThr-10)

      THROMBOSIS AND HAEMOSTASIS
    81. Himber, J; Refino, CJ; Burcklen, L; Roux, S; Kirchhofer, D
      Inhibition of arterial thrombosis by a soluble tissue factor mutant and active site-blocked factors IXa and Xa in the guinea pig

      THROMBOSIS AND HAEMOSTASIS
    82. Shariat-Madar, Z; Mahdi, F; Schmaier, AH
      Factor XI assembly and activation on human umbilical vein endothelial cells in culture

      THROMBOSIS AND HAEMOSTASIS
    83. Bjorkman, S; Berntorp, E
      Pharmacokinetics of coagulation factors clinical relevance for patients with haemophilia

      CLINICAL PHARMACOKINETICS
    84. Malik, AK; Wang, JM; Kurachi, K
      Effects of a second intron on recombinant MFG retroviral vector - Brief report

      ARCHIVES OF VIROLOGY
    85. Devine, SM; Bartholomew, AM; Mahmud, N; Nelson, M; Patil, S; Hardy, W; Sturgeon, C; Hewett, T; Chung, T; Stock, W; Sher, D; Weissman, S; Ferrer, K; Mosca, J; Deans, R; Moseley, A; Hoffman, R
      Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion

      EXPERIMENTAL HEMATOLOGY
    86. Guidotti, JE; Mallet, VO; Parlier, D; Mitchell, C; Fabre, M; Jaffray, P; Lambert, M; Kahn, A; Gilgenkrantz, H
      Fas/CD95 pathway induces mouse liver regeneration and allows for highly efficient retrovirus-mediated gene transfer

      HEPATOLOGY
    87. Cameron-Smith, R; Harbour, C
      Removal of poliovirus type 1 from a protein mixture using an immunoaffinity chromatography column

      BIOMEDICAL CHROMATOGRAPHY
    88. Wilson, JM
      Adenovirus-mediated gene transfer to liver

      ADVANCED DRUG DELIVERY REVIEWS
    89. Gaberc-Porekar, V; Menart, V
      Perspectives of immobilized-metal affinity chromatography

      JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS
    90. Burnouf, T; Radosevich, M
      Affinity chromatography in the industrial purification of plasma proteins for therapeutic use

      JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS
    91. Picton, HM
      Activation of follicle development: The primordial follicle

      THERIOGENOLOGY
    92. Aird, WC
      Vascular bed-specific hemostasis: Role of endothelium in pathogenesis

      CRITICAL CARE MEDICINE
    93. Tomokiyo, K; Teshima, K; Nakatomi, Y; Watanabe, T; Mizuguchi, J; Nozaki, C; Nakagaki, T; Miyamoto, S; Funatsu, A; Iwanaga, S
      Induction of acquired factor IX inhibitors in cynomolgus monkey (Macaca fascicularis): A new primate model of hemophilia B

      THROMBOSIS RESEARCH
    94. Kogan, AE; Kardakov, DV; Khanin, MA
      Analysis of the activated partial thromboplastin time test using mathematical modeling

      THROMBOSIS RESEARCH
    95. Iijima, K; Murakami, M; Kimura, O; Murakami, F; Shimomura, T; Ikawa, S
      A dysfunctional factor X (factor X Kurayoshi) with a substitution of Arg139 for ser at the carboxyl-terminus of the light chain

      THROMBOSIS RESEARCH
    96. Elg, M; Carlsson, S; Gustafsson, D
      Effect of activated prothrombin complex concentrate or recombinant factor VIIa on the bleeding time and thrombus formation during anticoagulation with a direct thrombin inhibitor

      THROMBOSIS RESEARCH
    97. Stubbs, M; Lloyd, J
      A protocol for the dental management of von Willebrand's disease, haemophilia A and haemophilia B

      AUSTRALIAN DENTAL JOURNAL
    98. Hoffman, M; Monroe, DM
      The action of high-dose factor VIIa (FVIIa) in a cell-based model of hemostasis

      SEMINARS IN HEMATOLOGY
    99. Galan, AM; Tonda, R; Altisent, C; Maragall, S; Ordinas, A; Escolar, G
      Recombinant factor VIIa (NovoSeven (R)) restores deficient coagulation: Experience from an ex vivo model

      SEMINARS IN HEMATOLOGY
    100. Charlebois, TS; O'Connell, BD; Adamson, SR; Brink-Nilsson, H; Jernberg, M; Eriksson, B; Kelley, BD
      Viral safety of B-domain deleted recombinant factor VIII

      SEMINARS IN HEMATOLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 05/04/20 alle ore 03:08:56